Jefferies Financial Group Increases Corteva (NYSE:CTVA) Price Target to $97.00

Corteva (NYSE:CTVA) had its price objective raised by investment analysts at Jefferies Financial Group from $95.00 to $97.00 in a report issued on Thursday,MarketScreener reports. Jefferies Financial Group’s price target points to a potential upside of 21.14% from the stock’s previous close.

Several other analysts have also recently weighed in on CTVA. Mizuho lifted their price objective on Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday, April 15th. Rothschild & Co Redburn raised their target price on Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. CICC Research lifted their price target on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research report on Wednesday, February 11th. Oppenheimer increased their price objective on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Finally, BNP Paribas Exane raised their price objective on Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and a consensus price target of $86.62.

Corteva Trading Down 2.1%

NYSE:CTVA traded down $1.70 during midday trading on Thursday, reaching $80.07. 202,263 shares of the stock traded hands, compared to its average volume of 3,953,527. The stock has a market capitalization of $53.76 billion, a P/E ratio of 47.15, a PEG ratio of 2.88 and a beta of 0.59. The company has a fifty day moving average of $80.66 and a 200 day moving average of $72.48. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. Corteva has a 12 month low of $60.53 and a 12 month high of $85.63.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.88% and a net margin of 6.50%.The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same period last year, the company earned $1.13 EPS. The business’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts predict that Corteva will post 3.62 EPS for the current year.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.15% of the company’s stock.

Hedge Funds Weigh In On Corteva

A number of hedge funds have recently bought and sold shares of the company. Activest Wealth Management increased its stake in Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after purchasing an additional 200 shares in the last quarter. JPL Wealth Management LLC bought a new position in shares of Corteva in the third quarter worth approximately $25,000. Westfuller Advisors LLC lifted its stake in shares of Corteva by 2,764.3% in the first quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock worth $34,000 after buying an additional 387 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in shares of Corteva during the fourth quarter valued at approximately $27,000. Finally, Bank of Jackson Hole Trust bought a new stake in shares of Corteva during the fourth quarter valued at approximately $28,000. Institutional investors own 81.54% of the company’s stock.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.